Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 1.335 Q1 | 50 | 14 | 27 | 4907 | 98 | 27 | 1.10 | 350.50 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 4.568 Q1 | 70 | 7 | 32 | 1963 | 222 | 32 | 5.78 | 280.43 | |
3 | Pharmacological Reviews | journal | 9.450 Q1 | 254 | 16 | 88 | 4334 | 1849 | 85 | 19.61 | 270.88 | |
4 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.083 Q1 | 99 | 17 | 54 | 3595 | 195 | 50 | 2.86 | 211.47 | |
5 | Pharmacology and Therapeutics | journal | 3.796 Q1 | 233 | 111 | 274 | 19051 | 2587 | 270 | 8.84 | 171.63 | |
6 | Medicinal Research Reviews | journal | 2.645 Q1 | 150 | 30 | 78 | 5067 | 643 | 78 | 7.66 | 168.90 | |
7 | Advances in Pharmacology | journal | 0.320 Q3 | 86 | 14 | 96 | 2270 | 63 | 89 | 0.74 | 162.14 | |
8 | Critical Reviews in Toxicology | journal | 1.915 Q1 | 129 | 32 | 78 | 5087 | 466 | 72 | 5.55 | 158.97 | |
9 | Progress in Medicinal Chemistry | journal | 0.981 Q2 | 38 | 5 | 23 | 777 | 54 | 20 | 2.88 | 155.40 | |
10 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.517 Q1 | 82 | 13 | 36 | 1996 | 157 | 36 | 2.63 | 153.54 | |
11 | Natural Product Reports | journal | 2.741 Q1 | 211 | 75 | 138 | 11288 | 931 | 133 | 6.61 | 150.51 | |
12 | Annual Review of Pharmacology and Toxicology | journal | 11.263 Q1 | 224 | 24 | 69 | 3600 | 1674 | 69 | 24.02 | 150.00 | |
13 | Current Neuropharmacology | journal | 0.489 Q3 | 103 | 27 | 83 | 3824 | 86 | 79 | 0.94 | 141.63 | |
14 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.839 Q1 | 108 | 52 | 143 | 7350 | 751 | 137 | 5.98 | 141.35 | |
15 | Current Medicinal Chemistry | journal | 1.834 Q1 | 202 | 261 | 652 | 36052 | 3639 | 630 | 5.26 | 138.13 | |
16 | Drug Resistance Updates | journal | 2.935 Q1 | 132 | 17 | 78 | 2301 | 604 | 75 | 7.15 | 135.35 | |
17 | CNS and Neurological Disorders - Drug Targets | journal | 2.059 Q1 | 96 | 45 | 162 | 6068 | 794 | 147 | 4.47 | 134.84 | |
18 | Current Enzyme Inhibition | journal | 0.245 Q3 | 19 | 25 | 29 | 3343 | 22 | 29 | 0.76 | 133.72 | |
19 | Frontiers in Drug Design and Discovery | book series | 0.124 Q4 | 9 | 23 | 18 | 2910 | 5 | 17 | 0.28 | 126.52 | |
20 | Recent Patents on CNS Drug Discovery | journal | 0.398 Q3 | 36 | 22 | 25 | 2775 | 29 | 25 | 1.16 | 126.14 | |
21 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.499 Q3 | 52 | 22 | 27 | 2750 | 35 | 27 | 1.30 | 125.00 | |
22 | Current Pharmaceutical Design | journal | 1.781 Q1 | 183 | 337 | 1056 | 38981 | 5047 | 939 | 4.98 | 115.67 | |
23 | Current Cancer Drug Targets | journal | 2.814 Q1 | 103 | 79 | 146 | 9022 | 840 | 143 | 5.77 | 114.20 | |
24 | Current Drug Targets | journal | 1.433 Q1 | 119 | 137 | 323 | 15626 | 1350 | 290 | 4.19 | 114.06 | |
25 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.211 Q3 | 27 | 35 | 141 | 3958 | 60 | 126 | 0.40 | 113.09 | |
26 | Current Gene Therapy | journal | 1.447 Q1 | 80 | 42 | 144 | 4712 | 670 | 139 | 4.93 | 112.19 | |
27 | Infectious Disorders - Drug Targets | journal | 1.158 Q1 | 61 | 35 | 89 | 3848 | 270 | 83 | 2.97 | 109.94 | |
28 | Advanced Drug Delivery Reviews | journal | 3.073 Q1 | 366 | 117 | 371 | 12760 | 3256 | 304 | 7.93 | 109.06 | |
29 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 23 | 28 | 2501 | 21 | 28 | 0.75 | 108.74 | ||
30 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.204 Q3 | 17 | 38 | 39 | 4108 | 8 | 34 | 0.21 | 108.11 | |
31 | Current Drug Metabolism | journal | 1.367 Q1 | 122 | 76 | 150 | 8173 | 850 | 144 | 4.97 | 107.54 | |
32 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.716 Q2 | 43 | 35 | 100 | 3696 | 233 | 100 | 2.16 | 105.60 | |
33 | Expert Opinion on Emerging Drugs | journal | 0.950 Q2 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 | |
34 | Current Bioactive Compounds | journal | 31 | 17 | 0 | 1782 | 0 | 0 | 0.00 | 104.82 | ||
35 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 22 | 30 | 2265 | 26 | 30 | 0.87 | 102.95 | ||
36 | Mini-Reviews in Medicinal Chemistry | journal | 1.113 Q1 | 107 | 114 | 339 | 11701 | 1183 | 322 | 3.32 | 102.64 | |
37 | Anti-Infective Agents | journal | 0.457 Q3 | 26 | 24 | 75 | 2422 | 83 | 69 | 0.92 | 100.92 | |
38 | Current Pharmacogenomics | journal | 0.218 Q3 | 12 | 27 | 89 | 2689 | 55 | 89 | 0.67 | 99.59 | |
39 | Expert Opinion on Therapeutic Targets | journal | 1.433 Q1 | 106 | 134 | 227 | 13332 | 756 | 212 | 3.39 | 99.49 | |
40 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.866 Q2 | 45 | 32 | 115 | 3098 | 306 | 108 | 2.62 | 96.81 | |
41 | Neurotoxicity Research | journal | 1.087 Q1 | 84 | 46 | 169 | 4442 | 541 | 168 | 3.36 | 96.57 | |
42 | Current Vascular Pharmacology | journal | 1.362 Q1 | 69 | 33 | 116 | 3168 | 482 | 111 | 4.51 | 96.00 | |
43 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.743 Q2 | 100 | 67 | 120 | 6384 | 333 | 118 | 2.78 | 95.28 | |
44 | Current Computer-Aided Drug Design | journal | 0.210 Q4 | 32 | 24 | 28 | 2269 | 16 | 26 | 0.57 | 94.54 | |
45 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 6 | 22 | 556 | 2 | 22 | 0.07 | 92.67 | ||
46 | Cellular and Molecular Life Sciences | journal | 3.265 Q1 | 261 | 275 | 804 | 25263 | 4711 | 800 | 5.76 | 91.87 | |
47 | Current Pharmaceutical Biotechnology | journal | 0.951 Q1 | 97 | 48 | 166 | 4332 | 511 | 144 | 2.47 | 90.25 | |
48 | Annual Report of Shionogi Research Laboratory | journal | 0.105 Q4 | 2 | 2 | 4 | 180 | 0 | 4 | 0.00 | 90.00 | |
49 | Food and Drug Law Journal | journal | 0.168 Q3 | 23 | 42 | 101 | 3769 | 35 | 99 | 0.35 | 89.74 | |
50 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 624 | 0 | 0 | 0.00 | 89.14 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®